Passage Bio, Inc. (PASG) Q1 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Passage Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:03.873 Thank you for holding. Good morning and welcome to the Passage Bio first quarter 2022 00:00:03.873 -- 00:00:06.475 financial and operating results conference call. 00:00:06.475 -- 00:00:09.258 All participants are in a listen-only mode. 00:00:09.258 -- 00:00:12.241 Following the formal remarks, we will open the call for your questions. 00:00:12.241 -- 00:00:15.524 Please be advised this call is being recorded at the company's request. 00:00:15.524 -- 00:00:18.727 At this time, I'd like to turn the call over to Stuart Henderson, Vice President of Corporate 00:00:18.727 -- 00:00:22.210 Development and Investor Relations. Stuart, please proceed. 00:00:22.210 -- 00:00:26.266 Thank you, Operator. This morning, we issued a press release that outlines the topics 00:00:26.266 -- 00:00:30.669 we plan to discuss today. This release is available on the Passage Bio website under 00:00:30.669 -- 00:00:35.293 the Press Releases and Statements section of Investors & News. 00:00:35.293 -- 00:00:39.776 On today's call, Bruce Goldsmith, President and Chief Executive Officer, will review 00:00:39.776 -- 00:00:45.160 our first quarter 2022 and recent business highlights, and Simona King, 00:00:45.160 -- 00:00:50.303 our Chief Financial Officer, will review our first quarter 2022 financial results. 00:00:50.700 -- 00:00:54.823 Before we begin, please note that today's call may include a number of forward-looking 00:00:54.823 -- 00:00:59.767 statements, including but not limited to comments on our expectations about timing and 00:00:59.767 -- 00:01:04.450 execution of anticipated milestones, including the initiation of clinical trials and 00:01:04.450 -- 00:01:09.594 the availability of clinical data from such trials, our expectation about our collabora...